Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial

Circulation ◽

10.1161/circulationaha.114.013255 ◽

2015 ◽

Vol 131 (1) ◽

pp. 34-42 ◽

Author(s):

Marc A. Pfeffer ◽

Brian Claggett ◽

Susan F. Assmann ◽

Robin Boineau ◽

Inder S. Anand ◽

...

Keyword(s):

Heart Failure ◽

Cardiac Function ◽

Regional Variation ◽

Aldosterone Antagonist

Download Full-text

Faculty Opinions recommendation of Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725241329.793503218 ◽

2015 ◽

Author(s):

Wilbert Aronow

Keyword(s):

Heart Failure ◽

Cardiac Function ◽

Regional Variation ◽

Aldosterone Antagonist

Download Full-text

Faculty Opinions recommendation of Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725241329.793504536 ◽

2015 ◽

Author(s):

Barry Greenberg

Keyword(s):

Heart Failure ◽

Cardiac Function ◽

Regional Variation ◽

Aldosterone Antagonist

Download Full-text

Faculty Opinions recommendation of Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718180959.793489610 ◽

2014 ◽

Author(s):

Chim Lang

Keyword(s):

Heart Failure ◽

Ejection Fraction ◽

Cardiac Function ◽

Structure And Function ◽

Cardiac Structure ◽

Preserved Ejection Fraction ◽

Aldosterone Antagonist ◽

Echocardiographic Study ◽

Cardiac Structure And Function ◽

Download Full-text

P3565Risk of atrial fibrillation in heart failure with preserved ejection fraction: results from the treatment of cardiac function with an aldosterone antagonist (TOPCAT) Study

European Heart Journal ◽

10.1093/eurheartj/ehx504.p3565 ◽

2017 ◽

Vol 38 (suppl_1) ◽

Author(s):

J. Neefs ◽

N.W.E. Van Den Berg ◽

W.R. Berger ◽

E.R. Meulendijks ◽

J.R. Groot

Keyword(s):

Heart Failure ◽

Atrial Fibrillation ◽

Ejection Fraction ◽

Cardiac Function ◽

Preserved Ejection Fraction ◽

Aldosterone Antagonist

Download Full-text

USE OF MACHINE LEARNING METHODOLOGY TO FIND PREDICTORS OF ALL-CAUSE MORTALITY IN THE TREATMENT OF PRESERVED CARDIAC FUNCTION HEART FAILURE WITH AN ALDOSTERONE ANTAGONIST TRIAL (TOPCAT)

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(20)31655-7 ◽

2020 ◽

Vol 75 (11) ◽

pp. 1028

Author(s):

Gauri Dandi ◽

Nuha Gani ◽

Zyannah Mallick ◽

Victoria Xin ◽

Ian Atkinson ◽

...

Keyword(s):

Machine Learning ◽

Heart Failure ◽

Cardiac Function ◽

Aldosterone Antagonist ◽

All Cause Mortality

Download Full-text

Sex Differences in Echocardiographic Parameters and Survival in the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial

Heart Lung and Circulation ◽

10.1016/j.hlc.2018.06.193 ◽

2018 ◽

Vol 27 ◽

pp. S129

Author(s):

A. Beale ◽

S. Nanayakkara ◽

D. Kaye

Keyword(s):

Heart Failure ◽

Sex Differences ◽

Cardiac Function ◽

Aldosterone Antagonist ◽

Echocardiographic Parameters

Download Full-text

Physical Activity and Prognosis in the TOPCAT Trial (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist)

Circulation ◽

10.1161/circulationaha.117.028002 ◽

2017 ◽

Vol 136 (11) ◽

pp. 982-992 ◽

Author(s):

Sheila M. Hegde ◽

Brian Claggett ◽

Amil M. Shah ◽

Eldrin F. Lewis ◽

Inder Anand ◽

...

Keyword(s):

Physical Activity ◽

Heart Failure ◽

Cardiac Function ◽

Aldosterone Antagonist ◽

Trial Treatment

Download Full-text

Rationale and design of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial: A randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction

American Heart Journal ◽

10.1016/j.ahj.2011.09.007 ◽

2011 ◽

Vol 162 (6) ◽

pp. 966-972.e10 ◽

Author(s):

Akshay S. Desai ◽

Eldrin F. Lewis ◽

Rebecca Li ◽

Scott D. Solomon ◽

Susan F. Assmann ◽

...

Keyword(s):

Heart Failure ◽

Ejection Fraction ◽

Cardiac Function ◽

Randomized Controlled Study ◽

Controlled Study ◽

Preserved Ejection Fraction ◽

Symptomatic Heart Failure ◽

Aldosterone Antagonist ◽

Randomized Controlled

Download Full-text

Baseline Distribution of Participants With Depression and Impaired Quality of Life in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist Trial

Circulation Heart Failure ◽

10.1161/circheartfailure.114.001838 ◽

2015 ◽

Vol 8 (2) ◽

pp. 268-277 ◽

Author(s):

Carine E. Hamo ◽

John F. Heitner ◽

Marc A. Pfeffer ◽

Hae-Young Kim ◽

Christopher T. Kenwood ◽

...

Keyword(s):

Quality Of Life ◽

Heart Failure ◽

Cardiac Function ◽

Aldosterone Antagonist ◽

Impaired Quality

Download Full-text

Impact of Spironolactone on Longitudinal Changes in Health-Related Quality of Life in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist Trial

Circulation Heart Failure ◽

10.1161/circheartfailure.114.001937 ◽

2016 ◽

Vol 9 (3) ◽

Author(s):

Eldrin F. Lewis ◽

Hae-Young Kim ◽

Brian Claggett ◽

John Spertus ◽

John F. Heitner ◽

...

Keyword(s):

Quality Of Life ◽

Heart Failure ◽

Cardiac Function ◽

Health Related Quality ◽

Aldosterone Antagonist ◽

Longitudinal Changes ◽

Related Quality ◽

Download Full-text